Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
J.Mackay-SimA.NortonR.CurrieB
Through these dynamic changes, astrocytes reshape their interactions with synapses, blood vessels and immune cellsmanifested through changes in calcium (Ca) signaling, neurotransmitter uptake, metabolic support and secretion of gliotransmitters and cytokines
Among these, the specialty clinics segment dominated the market in 2025 and is expected to maintain strong growth throughout the forecast period
The results were promising: the triple agonists were more effective at reducing body weight and increasing energy expenditure compared to GLP-1 receptor mono-agonists and GLP-1 receptor/GIP receptor co-agonists
Survodutide is another dual agonist in the pipeline with encouraging phase 2 data
The global obesity GLP-1 market is valued at USD 8,169 million in 2025
US$ 28.49
US$ 26.04
US$ 22.43
US$ 29.37
US$ 25.80
US$ 24.53
US$ 24.22
US$ 24.82
US$ 26.32
US$ 20.12
US$ 25.83
US$ 24.51
